Navigation Links
Colorcon, Inc. Quality by Design (QbD) Expertise Beneficial in Compliance with New FDA Guidelines
Date:9/19/2012

WEST POINT, Pa., Sept. 19, 2012 /PRNewswire/ -- Colorcon, Inc., (http://www.colorcon.com) a world leader in the development and supply of formulated coatings and other excipients for the pharmaceutical and nutritional supplement industries, announces customer access to valuable expertise in film coating formulation and process applications to assist pharmaceutical manufacturers with their Quality by Design (QbD) initiatives. Starting in January 2013, the FDA expects drug manufacturers to implement QbD principles in their Abbreviated New Drug Applications (ANDA).  The FDA QbD guidelines provide guidance on pharmaceutical product development and manufacturing to facilitate design of products and processes that maximizes the product's efficacy and safety while enhancing product manufacturability.

"For more than fifty years, Colorcon has remained a credible, industry-leading, partner in the development of fully formulated coating systems and has worked alongside formulators and drug product manufacturers while offering superior technical support," said Kamlesh Oza, General Manager, Film Coatings. "This plethora of experience puts Colorcon at the forefront in providing customers with industry leading insight into QbD principles for film coating.  Pharmaceutical companies can feel confident knowing that QbD principles have been used to develop and manufacture robust Opadry® fully formulated film coating products and systems in all Colorcon facilities world-wide that are consistent, predictable, reliable and controlled."

Colorcon has resources available for its customers as they prepare to meet the new FDA expectations.  Additionally, to provide its customers with valuable technical knowledge, Colorcon has hosted a series of webinars on the topic of QbD for the Pharmaceutical Industry.  To access previous webinars, please visit http://www.colorcon.com/formulation/education/webinars.

About Colorcon Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1,200 employees exclusively dedicated to its customer base.

For additional information, visit http://www.colorcon.com. CONTACT:Diane ReitterGlobal Communication Directordreitter@colorcon.com215-661-2639


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
2. Millstone Medical Outsourcing Hires New Vice President Quality
3. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
4. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
5. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
6. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
7. Total Therapeutic Management, Inc. invites directors of quality improvement to learn secrets of provider engagement strategies
8. NeuroSigma Receives Global Quality Control Certification
9. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
10. FDAnews announces Fourth Annual Supplier Quality Congress
11. New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
Breaking Medicine News(10 mins):